Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites

European Journal of Pharmacology

Volumn 392, Issue 1-2, 2000, Pages 41-49

  Polidori, Carlo ^a   Gentili, Francesco ^a   Pigini, Maria ^a   Quaglia, Wilma ^a   Panocka, Izabela ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Benazoline; Food intake; Idazoxan; Imidazoline I2 receptor ligand; Metrazoline; RX821002; Tracizoline; Water intake

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 NITROTRACIZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; IDAZOXAN; IMIDAZOLINE I2 RECEPTOR; METIZOLINE; METRAZOLINE; TRACIZOLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN FOURTH VENTRICLE; BRAIN LATERAL VENTRICLE; BRAIN THIRD VENTRICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEEDING; FEEDING BEHAVIOR; FLUID INTAKE; FOOD INTAKE; HYPERPHAGIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; BINDING SITES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; IDAZOXAN; IMIDAZOLES; MALE; RATS; RATS, WISTAR; RECEPTORS, DRUG;

EID: 0034708671     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00014-5     Document Type: Article

References (51)

1. 3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;39-47.
2. Bernstein I.L., Treneer C.M., Kott J.N. Area postrema mediates tumor effects on food intake, body weight and learned aversions. Am. J. Physiol. 249:1985;R296-R300.
3. Bousquet P. Imidazoline receptors: from basic concepts to recent developments. J. Cardiovasc. Pharmacol. 26:1995;S1-S6.
4. Bousquet P., Feldman J., Bloch R., Schwartz J. Central cardiovascular effect of α-adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230:1984;232-236.
5. Bricca G., Dontenwill M., Molines A., Feldman J., Belcourt A., Bousquet P. The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. Eur. J. Pharmacol. 162:1989;1-9.
6. 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain. Br. J. Pharmacol. 99:1990;803-809.
7. Bruban V., Feldman J., Dontenwill M., Greney H., Brasili L., Giannella M., Pigini M., Bousquet P. An unexpected central hypertensive effect of the new imidazoline compound, benazoline. Ann. N.Y. Acad. Sci. 1999;. in press.
8. Carrieri A., Brasili L., Leonetti F., Pigini M., Giannella M., Bousquet P., Carotti A. 2-D and 3-D modeling of imidazoline receptor ligands: insights into pharmacophore. Bioorg. Med. Chem. 5:1997;843-856.
9. Dourish C.T., Hutson P.H., Curzon G. Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin(8-OH-DPAT) elicit feeding in rats. Psychopharmacology. 86:1985;197-204.
10. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Morgan N.G., Wilson V.G., Dillon M.P. Seeking through a glass darkly: casting light on imidazoline 'I' sites. Trends Pharmacol. Sci. 19:1998;381-390.
11. 2 subtypes. Fund. Clin. Pharmacol. 6:1992;18.
12. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. 15(Suppl. 1):1997;S9-S23.
13. 1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signalling. Ann. N.Y. Acad. Sci. 763:1995;22-42.
14. 2-adrenoceptors in ventrolateral medulla. Eur. J. Pharmacol. 143:1987;1-13.
15. 3H]-idazoxan binding sites. Br. J. Pharmacol. 118:1996;2028-2036.
16. 2 sites in the mammalian central nervous system. Pharmacol. Ther. 68:1995;175-208.
17. Garcia-Sevilla, J.A., Meana Martinez, J.J., Barturen Fernandez, F., Geijo Caballero, F.A., Menargues Banos, A., Obach Vidal, R., Pla Rodas, F., 1993. Benzofuranylimidazole derivatives. UK Patent Application GB2 262 739 A.
18. 2 adrenergic antagonist idazoxan correlates with blood glucose levels. Psychopharmacology. 133:1997;172-178.
19. 1A receptor mechanisms are not involved in idazoxan-induced hyperphagia. Br. J. Pharmacol. 111:1994;145P.
20. 2-adrenoceptor antagonists on food and water intake in the rat. Br. J. Pharmacol. 104:1991;258-262.
21. Jackson H.C., Nutt D.J. Imidazoline receptors and ingestion. Cooper S.J., Clifton P.G. Drug Receptor Subtypes and Ingestive Behaviour. 1996;267-283 Academic Press, London.
22. 2-adrenoceptors in rabbit adipocyte membranes. Eur. J. Pharmacol. 159:1989;199-203.
23. 2-adrenergic binding sites. Mol. Pharmacol. 37:1990;876-885.
24. +. J. Phramacol. Exp. Ther. 276:1996;359-364.
25. 1A autoreceptors modulating serotonin synthesis in the rat brain in vivo. Neurosci. Lett. 218:1996;111-114.
26. 2 imidazoline receptors. Br. J. Pharmacol. 116:1995;1729-1736.
27. Mallard N.J., Hudson A.L., Nutt D.J. Characterization and autoradiographic localization of non-adrenoceptor binding sites in the rat brain. Br. J. Pharmacol. 106:1992;1019-1027.
28. 2-imidazoline sites. Br. J. Pharmacol. 111:1994;298P.
29. 2-adrenergic drugs also bind with high affinity to a nonadrenergic site. Mol. Pharmacol. 35:1989;324-330.
30. 3H]RX821002 (2-methoxy idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther. 264:1993;1187-1197.
31. 2 imidazoline and sigma binding sites in the rat and human stomach. J. Pharmacol. Exp. Ther. 285:1998;170-177.
32. 3H]-idazoxan binding sites in human cardiovascular tissues. Br. J. Pharmacol. 122:1997;43-50.
33. Morgan N.G., Chan S.L., Brown C.A., Tsoli E. Characterization of the imidazoline binding site involved in regulation of insulin secretion. Ann. N.Y. Acad. Sci. 763:1995;361-373.
34. Nutt D.J., French N., Handley S., Hudson A., Husbands S., Jackson H., Jordan S., Lalies M.D., Lewis J., Lione L., Mallard N., Pratt J. Functional studies of specific imidazoline-2 receptor ligands. Ann. N.Y. Acad. Sci. 763:1995;125-140.
35. 2-imidazoline receptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;709-716.
36. Orosco M., Nicolaidis S. Insulin and serotonin actions and interactions and the control of feeding and metabolism. Cooper S.J., Clifton P.G. Drug Receptor Subtypes and Ingestive Behaviour. 1996;99-126 Academic Press, London.
37. 2-imidazoline receptors in rat liver. Br. J. Pharmacol. 121:1997;901-912.
38. Parini A., Moudanos C.G., Pizzinat N., Lanier S.M. The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17:1996;13-16.
39. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. 1986;Academic Press, Australia, North Ryde, N.S.W., Australia.
40. Pigini M., Bousquet P., Brasili L., Carrieri A., Cavagna R., Dontenwill M., Gentili F., Giannella M., Leonetti F., Piergentili A., Quaglia W., Carotti A. Binding of tracizoline to the imidazoline receptor: the role of lipophylicity in quantitative structure-activity relationship models. Bioorg. Med. Chem. 6:1998;2245-2260.
41. Pigini M., Bousquet P., Carotti A., Dontenwill M., Giannella M., Moriconi R., Piergentili A., Quaglia W., Tayebati S.K., Brasili L. Imidazoline receptors: qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity. Bioorg. Med. Chem. 5:1997;833-841.
42. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol. 36:1996;511-544.
43. Reis D.J., Bousquet P., Parini A. The imidazoline receptor: pharmacology, functions, ligands and relevance to biology and medicine. Ann. N.Y. Acad. Sci. 763:1995;1-707.
44. Ruggiero D.A., Regunatan S., Wang H., Milner T.A., Reis D.J. Immunocytochemical localization of an imidazoline receptor protein in the central nervous system. Brain Res. 780:1998;270-293.
45. 1A receptor responsiveness? Br. J. Pharmacol. 95:1988;875P.
46. 2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia. J. Psychiatr. Res. 33:1999;251-251.
47. 2-adrenoreceptor antagonists. J. Med. Chem. 28:1985;1054-1062.
48. Sugrue M.F. Neuropharmacology of drugs affecting food intake. Pharmacol. Ther. 32:1987;145-182.
49. 2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270:1995;9856-9861.
50. Tesson F., Prip-Buus C., Lemoine A., Pegorier J.P., Parini A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. J. Biol. Chem. 266:1991;155-160.
51. 2-adrenergic receptors. Life Sci. 53:1993;669-680.